Garrod lecture: achieving the UNGA AMR mortality reduction goals

  13 March 2026

The article examines how the global community could achieve the United Nations goal to reduce deaths associated with antimicrobial resistance (AMR). It argues that current approaches to antibiotics—focused mainly on stewardship and innovation separately—are insufficient and that a broader systemic strategy is needed.

Key points:

  • Scale of the problem:
    Around 7.7 million deaths annually are associated with bacterial infections, with nearly 5 million linked to antibiotic resistance, highlighting the urgency of coordinated action.

  • The “four-box” framework for antibiotics:
    The authors propose a conceptual model describing four groups of patients with bacterial infections:

    1. Those whose infections could be prevented (e.g., via vaccination or infection control).

    2. Those treatable with existing antibiotics if access were improved.

    3. Those needing new antibiotics because resistance limits treatment options.

    4. Those who may remain difficult to treat even with innovation.
      This framework helps illustrate where interventions can reduce mortality.

  • Three major policy priorities:

    1. Prevent infections through vaccination, sanitation, and infection control.

    2. Improve access and appropriate use of existing antibiotics globally.

    3. Stimulate sustainable antibiotic innovation, since the current market does not adequately support new drug development.

  • Key challenge:
    Antibiotic stewardship, access, and innovation are often treated as separate policy domains, but the authors stress that they must be addressed simultaneously and coherently to reduce AMR mortality.

Overall conclusion:
Achieving the global AMR mortality reduction target will require integrated strategies combining prevention, equitable access to effective antibiotics, and sustainable incentives for antibiotic development, rather than relying on any single intervention.

If useful, I can also convert this into a short LinkedIn-style summary tailored to your AMR audience (similar to the posts you often publish through AMR Insights / disAMR).

Author(s): Ramanan Laxminarayan
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!